Sustained release of neuron-specific enolase to serum in amateur boxers

Brain Injury

Volumn 23, Issue 9, 2009, Pages 723-726

  Zetterberg, Henrik ^a   Tanriverdi, Fatih ^b   Unluhizarci, Kursad ^b   Selcuklu, Ahmet ^b   Kelestimur, Fahrettin ^b   Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Biomarkers; Boxing; Brain injury; Neuron specific enolase

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FATTY ACID BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADOLESCENT; ADULT; ARTICLE; BOXING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME RELEASE; HUMAN; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; TRAUMATIC BRAIN INJURY;

EID: 69349092217     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050903120399     Document Type: Article

References (29)

1. Casson IR, Siegel O, Sham R, Campbell EA, Tarlau M, DiDomenico A. Brain damage in modern boxers. Journal of the American Medical Association 1984;251:2663-2667.
2. Jordan BD. Chronic traumatic brain injury associated with boxing. Seminars in Neurology 2000;20:179-185.
3. Kemp PL. A critique of published studies into the effects of amateur boxing: Why is there a lack of consensus? Journal of the Royal Naval Medical Service 1995;81:182-189.
4. Haglund Y, Eriksson E. Does amateur boxing lead to chronic brain damage? A review of some recent investigations. American Journal of Sports Medicine 1993;21:97-109.
5. Zetterberg H, Hietala MA, Jonsson M, Andreasen N, Styrud E, Karlsson I, Edman A, Popa C, Rasulzada A, Wahlund LO, et al. Neurochemical aftermath of amateur boxing. Archives of Neurology 2006;63:1277-1280.
6. Kelestimur F, Tanriverdi F, Atmaca H, Unluhizarci K, Selcuklu A, Casanueva FF. Boxing as a sport activity associated with isolated GH deficiency. Journal of Endocrinological Investigations 2004;27:RC28-32.
7. Tanriverdi F, Unluhizarci K, Kocyigit I, Tuna IS, Karaca Z, Durak AC, Selcuklu A, Casanueva FF, Kelestimur F. Brief communication: Pituitary volume and function in competing and retired male boxers. Annals of Internal Medicine 2008;148:827-831.
8. Hergenroeder GW, Redell JB, Moore AN, Dash PK. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Molecular Diagnosis and Therapy 2008;12:345-358.
9. Korhonen L, Riikonen R, Nawa H, Lindholm D. Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia. Neuroscience Letters 1998;240:151-154.
10. Pelsers MM, Hanhoff T, Van der Voort D, Arts B, Peters M, Ponds R, Honig A, Rudzinski W, Spener F, de Kruijk JR, et al. Brain- and heart-type fatty acid-binding proteins in the brain: Tissue distribution and clinical utility. Clinical Chemistry 2004;50:1568-1575.
11. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh el O. Development of a high-throughput automated analyzer using biochip array technology. Clinical Chemistry 2005;51: 1165-1176.
12. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Current Opinion in Critical Care 2008;14:135-141.
13. Bandyopadhyay S, Hennes H, Gorelick MH, Wells RG, Walsh-Kelly CM. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Academic Emergency Medicine 2005;12:732-738.
14. Beers SR, Berger RP, Adelson PD. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. Journal of Neurotrauma 2007;24:97-105.
15. Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. Journal of Neurosurgery 2005;103:61-68.
16. McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochirurgica. Supplement 1998;71:117-119.
17. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. Association of serial biochemical markers with acute ischemic stroke: The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006;37:2508-2513.
18. Oertel M, Schumacher U, McArthur DL, Kastner S, Boker DK. S-100B and NSE: Markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. Journal of Clinical Neuroscience 2006;13: 834-840.
19. Selakovic V, Raicevic R, Radenovic L. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. Journal of Clinical Neuroscience 2005;12: 542-547.
20. Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clinical Neurology and Neurosurgery 2006;108: 558-563.
21. Auer J, Berent R, Weber T, Porodko M, Lamm G, Lassnig E, Maorer E, Mayr H, Punzengruber C, Eber B. Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. Canadian Journal of Emergency Medicine 2006;8:13-18.
22. Grubb NR, Simpson C, Sherwood RA, Abraha HD, Cobbe SM, O'Carroll RE, Deary I, Fox KA. Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100. Heart 2007;93:1268-1273.
23. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. Journal of Neurotrauma 2007;24: 1793-1801.
24. Stalnacke BM, Ohlsson A, Tegner Y, Sojka P. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game. British Journal of Sports Medicine 2006;40:313-316.
25. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999;30:1190-1195.
26. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Kochanek PM. Serum S100B concentrations are increased after closed head injury in children: A preliminary study. Journal of Neurotrauma 2002;19:1405-1409.
27. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology of Aging 2005;26:115-123.
28. Wunderlich MT, Hanhoff T, Goertler M, Spener F, Glatz JF, Wallesch CW, Pelsers MM. Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. Journal of Neurology 2005;252: 718-724.
29. Guleria S, Gupta RK, Saksena S, Chandra A, Srivastava RN, Husain M, Rathore R, Narayana PA. Retrograde Wallerian degeneration of cranial corticospinal tracts in cervical spinal cord injury patients using diffusion tensor imaging. Journal of Neuroscience Research 2008;86: 2271-2280.